Heretic
Therapy

PRP and stem cells

Your own platelets, concentrated and re-injected, have decent trials behind them. The stem cell side is much murkier.

Updated 15 Oct 20262 sources4 min read
Short answer

PRP concentrates your own platelets to deliver growth factors to damaged tissue; stem cell therapy delivers progenitor cells that work mainly through paracrine signaling. PRP has real trial support: multiple randomized trials show it beating hyaluronic acid and saline in knee osteoarthritis, plus positive data in tendinopathy and hair loss, with an excellent safety profile as an autologous product. Stem cell evidence is weaker and most orthopedic stem cell treatments are not FDA-approved, with unregulated clinics a real hazard.

Summary drafted from this entry’s sources; editorial review pending.

01Key questions

Does PRP work for joint pain?

The best evidence is in knee osteoarthritis, where multiple randomized trials found PRP superior to hyaluronic acid and saline, with benefits lasting 6 to 12 months. It also has positive trials in tennis elbow, Achilles tendinopathy and androgenic hair loss. Rotator cuff data are mixed.

Do stem cell injections work?

Moderate at best. Intra-articular MSC injections for knee arthritis show pain relief and functional improvement with durability out to one or two years in some studies; imaging evidence of actual cartilage regeneration is contested. Disc and tendon applications are pilot-stage.

Are these treatments legal and regulated?

PRP is routine autologous practice. Most stem cell therapies for orthopedic use are not FDA-approved; clinics operate under exemptions or research protocols, umbilical-cord products have drawn FDA action, and the field has documented operators using non-viable products.

Are PRP and stem cells safe?

PRP is about as safe as injections get: your own blood, no allergy risk, mostly injection-site effects. Autologous MSCs are generally safe too; donor-cell products carry more immune and regulatory concern, and serious adverse events have been reported mainly at unregulated clinics.

What would change this rating?

Larger standardized randomized trials for stem cells in orthopedic indications, and head-to-head data on which PRP formulation (leukocyte-rich versus poor) works where. Product standardization is the big unresolved variable.

Core thesis: Platelet-rich plasma (PRP) and stem cell therapies represent the biological frontier of regenerative medicine. By concentrating the body's own healing factors (PRP) or delivering progenitor cells (stem cells) directly to damaged tissue, these approaches can promote genuine tissue repair rather than merely managing symptoms.


02Platelet-Rich Plasma (PRP)

What Is PRP?

  • Autologous (from your own body) concentrate of platelets in a small volume of plasma
  • Platelets contain alpha granules packed with growth factors:
  • PDGF (platelet-derived growth factor) — cell proliferation, angiogenesis
  • TGF-β (transforming growth factor beta) — collagen production, tissue remodeling
  • VEGF (vascular endothelial growth factor) — new blood vessel formation
  • EGF (epidermal growth factor) — tissue regeneration
  • FGF (fibroblast growth factor) — fibroblast activation, wound healing
  • IGF-1 (insulin-like growth factor) — cell growth, tissue repair
  • Typical concentration: 3-8x baseline platelet count

PRP Preparation

  1. Blood draw: 20-60 mL of venous blood
  2. Centrifugation: Single or double spin to separate platelet-rich layer
  3. Activation: Calcium chloride or thrombin (optional) to trigger growth factor release
  4. Injection: Under ultrasound guidance into target tissue

Types of PRP

Type Characteristic Best For
Leukocyte-rich PRP (LR-PRP) Contains white blood cells Tendinopathy, chronic inflammation
Leukocyte-poor PRP (LP-PRP) Minimal white blood cells Osteoarthritis, intra-articular use
Platelet-poor plasma (PPP) Low platelets, high fibrin Used as scaffold in some protocols

Swipe table →

Clinical Evidence

Osteoarthritis (Moderate-Strong)

  • Multiple RCTs show PRP superior to hyaluronic acid and saline for knee OA
  • Improvements in pain, function, and quality of life sustained 6-12 months
  • PMID: PMC12604588 (2025) — "PRP therapy has emerged as a promising regenerative approach"
  • May slow cartilage degeneration (disease-modifying, not just symptom relief)

Tendinopathy (Moderate-Strong)

  • Achilles tendinopathy: PRP + eccentric exercise superior to exercise alone
  • Lateral epicondylitis: Multiple positive RCTs
  • Patellar tendinopathy: Growing evidence
  • Rotator cuff: Evidence mixed; surgical repair augmented with PRP shows benefit

Hair Loss (Androgenic Alopecia) (Moderate)

  • PRP injections into scalp promote hair follicle reactivation
  • Multiple RCTs show increased hair count and thickness
  • Maintenance sessions required every 3-6 months

Skin Rejuvenation ("Vampire Facial")

  • PRP + microneedling → collagen stimulation
  • Moderate evidence for skin quality improvement

03Stem Cell Therapies

What Are Stem Cells?

  • Undifferentiated cells capable of self-renewal and differentiation into specialized cell types
  • Paracrine effects: Stem cells secrete cytokines, growth factors, and exosomes that modulate the local environment and recruit endogenous repair cells
  • Immunomodulatory: MSCs can modulate immune responses, reduce inflammation

Types of Stem Cells

Type Source Characteristics Regulatory Status
MSCs (mesenchymal stromal cells) Bone marrow, adipose tissue, umbilical cord Most studied for orthopedic use; differentiate into bone, cartilage, fat Varies — largely research/off-label
Hematopoietic stem cells Bone marrow, peripheral blood Blood cell formation; established for blood disorders FDA-approved for specific conditions
Adipose-derived MSCs Fat tissue (liposuction) Abundant, easy to harvest Research/off-label
Umbilical cord-derived Birth tissue Young cells, high proliferative capacity Contested — FDA regulatory action

Swipe table →

Mechanism of Action

  1. Homing: Stem cells migrate to injury/damage sites
  2. Paracrine signaling: Secrete trophic factors that modulate local environment
  3. Anti-inflammatory: Reduce pro-inflammatory cytokines, increase anti-inflammatory
  4. Angiogenesis: Promote new blood vessel formation
  5. Differentiation: Can directly become tissue cells (bone, cartilage, etc.)
  6. Immunomodulation: Modulate T-cell responses, reduce autoimmune activity

Clinical Evidence

Osteoarthritis (Moderate)

  • Intra-articular MSC injection shows pain relief and functional improvement
  • Some imaging evidence of cartilage regeneration (contested)
  • PMID: PMC11575995 — growing interest in combining PRP with stem cells
  • Durable benefits reported at 1-2 year follow-up in some studies

Intervertebral Disc Disease (Emerging)

  • Intradiscal MSC injection shows promise for disc regeneration
  • Pain reduction and improved function in pilot studies
  • Potential to avoid spinal surgery in selected patients

Tendon and Ligament Repair (Emerging)

  • MSC injection into tendon defects shows improved healing in animal models
  • Human evidence is preliminary but promising
  • Often combined with PRP or scaffolds

Other Applications

  • Cardiac repair: Post-MI cardiac regeneration (research stage)
  • Neurological: Stroke, spinal cord injury, MS (early research)
  • Autoimmune: Immunomodulatory effects being explored for lupus, RA, Crohn's

04Safety and Regulation

PRP Safety

  • Excellent safety profile — autologous product, minimal risk
  • Adverse events: Mostly injection-related (pain, bruising, rare infection)
  • No allergic risk (your own blood)

Stem Cell Safety

  • Autologous MSCs (from your own body): Generally safe, minimal rejection risk
  • Allogeneic cells (donor): Higher regulatory concern, potential immune reaction
  • Serious adverse events: Rare but reported (especially with unregulated clinics)

The Regulatory Problem

  • FDA has not approved most stem cell therapies for orthopedic use
  • Many clinics operate under "same-day surgical exemption" or use research protocols
  • Unregulated clinics may use non-viable cell products or make exaggerated claims
  • The field is legitimate but the industry has grifters — vet clinics carefully

05Connections

Neighborhood · 8 linked entriesOpen full map →

06Sources

  1. Nguyen RT et al. (2024). "Biological Mechanisms of PRP." PMC12604588PMC12604588
  2. Fitzpatrick J et al. (2024). "PRP: A Bibliometric Analysis." PMC11575995PMC11575995

07Entry history

Latest content update.

Heretic informs and never prescribes. Where amounts appear, they describe what published studies used. Talk to a qualified clinician before acting on anything here.